Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

CG Oncology (CGON) Shares Outstanding (Weighted Average): 2023-2024

Historic Shares Outstanding (Weighted Average) for CG Oncology (CGON) over the last 2 years, with Dec 2024 value amounting to $67.6 million.

  • CG Oncology's Shares Outstanding (Weighted Average) rose 13.67% to $76.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $76.2 million, marking a year-over-year increase of 13.67%. This contributed to the annual value of $67.6 million for FY2024, which is 55.53% up from last year.
  • Per CG Oncology's latest filing, its Shares Outstanding (Weighted Average) stood at $67.6 million for FY2024, which was up 55.53% from $43.5 million recorded in FY2023.
  • CG Oncology's 5-year Shares Outstanding (Weighted Average) high stood at $67.6 million for FY2024, and its period low was $43.5 million during FY2023.
  • In the last 2 years, CG Oncology's Shares Outstanding (Weighted Average) had a median value of $55.6 million in 2023 and averaged $55.6 million.
  • Data for CG Oncology's Shares Outstanding (Weighted Average) shows a peak YoY skyrocketed of 55.53% (in 2024) over the last 5 years.
  • CG Oncology's Shares Outstanding (Weighted Average) (Yearly) stood at $43.5 million in 2023, then spiked by 55.53% to $67.6 million in 2024.